Breaking News

inVentiv Health Clinical Names Late-Stage EVP

By Kristin Brooks | February 5, 2014

Okamoto brings management and outcomes research expertise

Lynn Okamoto, Pharm.D., has been named executive vice president of the Late Stage Business Unit at inVentiv Health Clinical, effective March 3rd. Dr. Okamoto has experience as global manager with expertise in healthcare analytics and health outcomes research. She joins the company from Evidera, where she served as senior vice president and senior research scientist of Health Economics & Epidemiology. Previously she led the Intelligent Health Repository at NDC Health.
 
"inVentiv Health was built for this new marketplace, with the broadest range of convergent services in the industry," said Raymond Hill, president inVentiv Health Clinical. "Our Late Stage Clinical group works seamlessly with inVentiv experts in study design and implementation, market access, reimbursement, stakeholder relations and scientific communications to anticipate the questions that will be asked in the marketplace and assure our clients are armed with effective answers."
blog comments powered by Disqus
  • Quality Risk Management

    Quality Risk Management

    Cheryl Abernathy and Bryan Sasbon, Quality Assurance Operations Manager, Ropack Pharma Solutions; QA Director & Regulatory Affairs, Ropack Pharma Solutions||September 8, 2016
    Embracing the process as a means to a strong quality culture

  • Staying Ahead in the Small Molecule Space

    Staying Ahead in the Small Molecule Space

    Dr. Matthew Moorcroft, VP Global Marketing, Cambrex||September 8, 2016
    Understand what is happening in the market and react accordingly

  • FDA & Drug Development

    FDA & Drug Development

    Rachelle Du2019Souza, Regulatory Heights Inc.||September 8, 2016
    You must perform the necessary due diligence to stay on top of regulatory developments